GLP-1 use linked to fewer headaches in idiopathic intracranial hypertension

CHICAGO — Patients with idiopathic intracranial hypertension lost weight and had fewer headaches with GLP-1 receptor agonists, according to an abstract presented at the American Academy of Neurology Annual Meeting. Idiopathic intracranial hypertension (IIH) is “a serious neurological disorder presented clinically with chronic headaches, papilledema and visual loss,” Samar Shehata, MBBCh, a